Inflation Reduction Act

How are Medicare plans lowering drug costs for beneficiaries?

April 9, 2024 - Affordable access to prescription drugs is a necessity for managing chronic and acute conditions and staying healthy. However, as drug costs rise, both affordability and accessibility are dwindling. Over 80 percent of surveyed adults said the cost of prescription drugs is unreasonable, according to 2023 KFF data. Younger individuals who made less money and took four or more medications...


More Articles

9 Trends To Watch During ACA Marketplace 2024 Open Enrollment

by Kelsey Waddill

Going into the 2024 open enrollment season, healthcare stakeholders should be prepared for nine key trends in Affordable Care Act marketplace enrollment, according to experts from KFF. First,...

Price May Drive Affordable Care Act Marketplace Plan Selection

by Kelsey Waddill

The Affordable Care Act (ACA) marketplace was designed to incentivize enrollees to choose specific plans based on price and it seems to be fulfilling that goal, an analysis from the Urban Institute...

Medicare Part D Patients with HIV May See Lower Drug Costs Under IRA

by Kelsey Waddill

The Inflation Reduction Act’s Medicare Part D redesign may improve affordability for beneficiaries with HIV, but stakeholders will need to take steps to ensure beneficiaries get the most out of...

HHS Attributes Record Low Uninsurance Rate to ACA Enrollment

by Mark Melchionna

Following the Affordable Care Act (ACA) open enrollment period that concluded in January 2023, the United States Department of Health and Human Services (HHS) reported that uninsurance among American...

CMS Projects 2024 Medicare Part D Premiums Will Fall by 1.8%

by Victoria Bailey

Medicare Part D premiums are projected to decrease from $56.49 in 2023 to $55.50 in 2024, CMS announced. The projected average Part D premium represents the sum of the average basic premium and the...